Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

radiation oncology therapy treatment

Surveillance imaging of post-treatment cancer patients may cause more problems than it solves

After completing primary radiation therapy, patients in remission from cancers of the head and neck are better served by expectant management than routine imaging.

November 29, 2023
healthcare business deal

Roche, Ibex Medical Analytics and AWS partner for better cancer diagnostics

The three companies are partnering to bring AI tools to Roche’s digital pathology platform to streamline cancer diagnoses.

October 30, 2023
Video of Juan Carlos Plana Gomez MD explaining how to create a cardio-oncology program at ASE 2023. #ASE #ASE23 #ASE2023

How to create a cardio-oncology program

Juan Carlos Plana Gomez, MD, discussed how cardiology and oncology programs can work together to provide high-quality patient care.

September 8, 2023
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

July 6, 2023

SPECT/CT helps personalize treatment options for prostate cancer patients

Using SPECT/CT imaging, providers can stratify patients based on their treatment responses and make personalized adjustments accordingly.

June 29, 2023
whole-body pet scanner add-on device presented at #SNMMI 2023

New PET technology offers 'clear improvement' of whole-body scan resolution

The new technology achieves this by way of two add-on detectors that simultaneously scan patients during their whole-body PET exam.

June 26, 2023
Prostate Cancer

New prostate cancer PET imaging agent officially available for commercial use

Posluma (flotufolastat F 18) received the U.S. Food and Drug Administration’s approval in May 2023.

June 21, 2023
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 

Prostate cancer size is frequently underestimated on imaging

Newly published data recently revealed just how common the extent of prostate cancer is underestimated based on imaging measurements. 

June 12, 2023